Summary

The Global Neurovascular Devices Market is valued at USD 3,325 million in 2024 growing at a CAGR of 7.02% during the forecast period 2024-2035.

Neurovascular disorders are a category of neurological conditions characterized by impaired blood flow to the brain, spinal cord, and peripheral nerves. This disruption is often caused by issues with cerebral blood vessels, including blockages (embolism), ruptures (hemorrhage), clots (thrombosis), or narrowing (stenosis). Such disruptions result in insufficient oxygen and nutrient supply to the brain, leading to cell death (apoptosis) and subsequent permanent physical and mental impairments. Notably, neurovascular disorders rank among the top five life-threatening conditions worldwide, imposing a significant economic burden across various regions. According to the World Health Organization, these disorders lead to approximately 15 million new cases and five million deaths globally each year. Contributing factors to the development and increasing prevalence of neurovascular disorders include unhealthy lifestyles, physical trauma, malnutrition, brain injuries, and congenital abnormalities.
Currently, several traditional surgical approaches are employed to treat neurovascular disorders, such as open neurosurgery, microsurgery, craniotomy, and bypass surgery. However, these methods have limitations due to their complexity, time-intensive procedures, lower success rates, prolonged recovery periods, and the need for expert supervision and specialized surgical centers. To overcome these challenges, neurovascular devices have emerged as a promising treatment alternative. These devices offer precise, targeted, and minimally invasive interventional techniques. Examples include intracranial stents, embolic coils, flow diverters, guidewires, and catheters, which are designed for site-specific microsurgery in areas of the brain with compromised blood flow. Due to these technological advancements, neurovascular devices are now considered innovative treatment options for neurovascular disorders. With ongoing research, innovation, and growing investor interest, the neurovascular devices market is expected to experience substantial growth in the coming years.
This market growth is also driving developments in related industries, such as the coating of neurovascular devices. Companies like Biocoat are providing specialized coatings for various medical devices, including custom coatings for neurovascular devices. Additionally, numerous medical device contract manufacturers are offering design, development, and production services to companies in the neurovascular device sector.


Key Market Segments
Type of Device
 Neurothrombectomy Devices
 Embolization Devices
 Angioplasty Devices
Therapeutic Application
 Ischemic Stroke
 Aneurysm
 Stenosis
 Arteriovenous Malformations (AVMs)
End Users
 Hospitals and Specialty Clinics
 Ambulatory Care Centers
 Other End Users
Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Midde East and North Africa
 Latin America
Key Leading Players
 Integer Holdings
 Johnson & Johnson
 Medtronic Inc.
 MicroVention
 Penumbra Inc.
 Shanghai HeartCare Medical Technology
 Stryker Corporation
Research Coverage:
 This report provides a general overview of the neurovascular disorders, featuring details on different types of neurovascular disorders along with the historical evolution of their treatment approaches. Further, it also projects information on the current scenario of treatment options for neurovascular disorders along with the types of neurovascular devices. Further, it features the recent advancements, challenges and future outlook associated with the neurovascular devices.
 Comprehensive outlook of the current market landscape of neurovascular device developers, along with information on their status of development (approved, commercialized and under development), type of device (accessory devices (catheters, guidewires and other accessory devices), angioplasty devices (revascularization, balloon occlusion devices and embolic protection systems) embolization devices (embolic coils / clippings, stent-assisted devices and other embolization devices), and neurothrombectomy devices (clot retrieval devices, aspiration / suction devices and other thrombectomy devices), therapeutic application (ischemic stroke, hemorrhagic stroke, aneurysms, arteriovenous malformations, arteriovenous fistulae, stenosis and others), material of fabrication and coating material of device. Further, this chapter provides an overview of the developers engaged in developing these devices, featuring a comprehensive analysis across several relevant parameters, such as their establishment year, company size (based on the employee count), location of headquarters. Moreover, this section also presents the most active players based on the number of neurovascular devices offered.
 Comprehensive company profiles of neurovascular device developers, featuring information on their year of establishment, location of headquarters, employee count, leadership team, financial information (if available), neurovascular device portfolio, recent developments and an informed future outlook.
 Comprehensive competitiveness analysis of the neurovascular devices across several relevant parameters, such as strength of the company (in terms of years of experience and company size), product portfolio strength (in terms of type of device, its status of development, region of approval, material of fabrication and coating material of device) and product portfolio diversity (number of therapeutic application).
 In-depth analysis of various partnerships and collaborations inked in the global neurovascular devices market between the stakeholders since 2019, across prominent parameters, such as such as year of the partnership, type of the partnership, type of the partner, type of device, therapeutic application, most active players (in terms of number of partnerships inked) and geographical analysis.
 Elaborate analysis of the funding and investments activity registered in the neurovascular device companies since 2019, including grants, private placement offerings, capital raised from seed financing, debt financing, venture series and other equity, at various stages of the device development. The funding and investments made by the stakeholders, were analyzed based on several relevant parameters, such as year-wise trend of the funding instances, type of funding, month and year of funding, total amount invested, geographical analysis of the funding and the investment, leading players (in terms of number of funding instances and amount raised) and investors (in terms of number of funding instances).
 An in-depth analysis in order to analyze the current and future demand for neurovascular devices, on the basis of several relevant parameters, such as type of device (neurothrombectomy devices, embolization devices and angioplasty devices), therapeutic application (ischemic stroke, aneurysm, stenosis and arteriovenous malformations (AVMs)), key geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and key leading players, till 2035.
 An in-depth analysis of the factors that can affect the growth of the neurovascular devices market. It features identification and analysis of key market drivers, potential market restraints, emerging opportunities in the market, and existing challenges encountered in the market.
 A detailed estimate of the current neurovascular devices market size and the future growth potential for neurovascular medical device developers over the next decade. Based on the multiple parameters, such as likely adoption of the trends and via reliable secondary and primary validations, we have projected an informed estimate on the market evolution during the forecast period till 2035. The report also features the likely distribution of the current and forecasted opportunity within the neurovascular devices industry. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the market growth.
 Comprehensive predictions of the current and future opportunity for neurovascular device developers in the market based on various types of devices, such as neurothrombectomy devices, embolization devices and angioplasty devices.
 Comprehensive projections of the current and future opportunity within the neurovascular devices market based on different therapeutic applications, such as ischemic stroke, aneurysm, stenosis and arteriovenous malformations (AVMs).
 Comprehensive projections of the current and future opportunity for neurovascular device developers in the market based on various end users, such as hospitals and specialty clinics, ambulatory care centers and other end users.
 Comprehensive projections of the current and future opportunity for neurovascular device developers in the market across key geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.
 Comprehensive predictions of the current revenues of the leading players in the neurovascular device domain, which includes Integer Holdings, Johnson & Johnson, Medtronic Inc., MicroVention, Penumbra Inc., Shanghai HeartCare Medical Technology and Stryker Corporation.
Key Benefits of Buying this Report
 The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
 Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
 The report provides stakeholders with a pulse on the Global Neurovascular Devices Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
 Acandis
 Achieva Medical
 Balt
 HeMo Bioengineering
 Johnson & Johnson
 Medtronic Inc.
 MicroVention
 Penumbra Inc.
 Phenox
 Shanghai HeartCare Medical Technology
 Stryker Corporation
 Zylox-Tonbridge

ページTOPに戻る

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rate
3.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risk Associated with Trade Barriers
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Neurovascular Disorders
5.3. Historical Milestones in the Neurovascular Disorders Treatment
5.4. Treatment of Neurovascular Disorders
5.5. Types of Neurovascular Devices
5.6. Recent Advancements in Neurovascular Devices
5.7. Challenges Associated with Neurovascular Devices
5.8. Future Perspectives
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Neurovascular Devices Market: Overall Market Landscape
6.2.1. Analysis by Status of Development
6.2.2. Analysis by Type of Device
6.2.3. Analysis by Therapeutic Application
6.2.4. Analysis by Type of Device and Therapeutic Application
6.2.5. Analysis by Material of Fabrication
6.2.6. Analysis by Coating Material of Device
6.3. Neurovascular Devices Market: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters (Region)
6.3.4. Analysis by Location of Headquarters (Country)
6.3.5. Analysis by Company Size and Location of Headquarters (Region)
6.3.6. Most Active Developers: Analysis by Number of Neurovascular Devices Developed
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Johnson & Johnson
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Neurovascular Device Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Medtronic
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Neurovascular Device Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. MicroVention
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Neurovascular Device Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Penumbra
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Neurovascular Device Portfolio
7.5.4. Recent Developments and Future Outlook
7.6. Stryker
7.6.1. Company Overview
7.6.2. Financial Information
7.6.3. Neurovascular Device Portfolio
7.6.4. Recent Developments and Future Outlook
7.7. Other Leading Players
7.7.1. Acandis
7.7.1.1. Company Overview
7.7.1.2. Neurovascular Device Portfolio
7.7.2. Achieva Medical
7.7.2.1. Company Overview
7.7.2.2. Neurovascular Device Portfolio
7.7.3. Balt
7.7.3.1. Company Overview
7.7.3.2. Neurovascular Device Portfolio
7.7.4. HeMo Bioengineering
7.7.4.1. Company Overview
7.7.4.2. Neurovascular Device Portfolio
7.7.5. Phenox
7.7.5.1. Company Overview
7.7.5.2. Neurovascular Device Portfolio
7.7.6. Shanghai HeartCare Medical Technology
7.7.6.1. Company Overview
7.7.6.2. Neurovascular Device Portfolio
7.7.7. Zylox-Tonbridge
7.7.7.1. Company Overview
7.7.7.2. Neurovascular Device Portfolio
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Product Competitiveness Analysis: Analysis by Location of Headquarters of Neurovascular Device Developers
8.4.1. Product Competitiveness Analysis: Neurovascular Devices Developed by Players based in North America
8.4.2. Product Competitiveness Analysis: Neurovascular Devices Developed by Players based in Europe
8.4.3. Product Competitiveness Analysis: Neurovascular Devices Developed by Players based in Asia-Pacific and Rest of the World
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Neurovascular Devices Market: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Partner
9.3.5. Analysis by Year of Partnership and Type of Partner
9.3.6. Analysis by Type of Partnership and Type of Partner
9.3.7. Analysis by Type of Device
9.3.8. Analysis by Therapeutic Application
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Local and International Agreements
9.3.10.2. Intracontinental and Intercontinental Agreements
10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Neurovascular Devices Market: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Type of Funding
10.3.3. Analysis by Year and Type of Funding
10.3.4. Analysis by Amount Invested
10.3.5. Analysis of Amount Invested by Type of Funding
10.3.6. Analysis by Geography
10.3.7. Most Active Players: Analysis by Number of Funding Instances
10.3.8. Most Active Players: Analysis by Amount Raised
10.3.9. Leading Investors: Analysis by Number of Funding Instances
10.4. Concluding Remarks
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Neurovascular Devices: Global Annual Demand
11.3.1. Analysis by Type of Device
11.3.2. Analysis by Therapeutic Application
11.3.3. Analysis by Key Geographical Regions
12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion
13. GLOBAL NEUROVASCULAR DEVICES MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Neurovascular Devices Market, till 2035
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario
13.3.1.2. Optimistic Scenario
13.4. Key Market Segmentations
14. NEUROVASCULAR DEVICES MARKET, BY TYPE OF DEVICE
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Neurovascular Devices Market: Distribution by Type of Device, 2019, current year and 2035
14.4. Neurovascular Devices Market for Neurothrombectomy Devices, till 2035
14.5. Neurovascular Devices Market for Embolization Devices, till 2035
14.6. Neurovascular Devices Market for Angioplasty Devices, till 2035
14.7. Data Triangulation and Validation
15. NEUROVASCULAR DEVICES MARKET, BY THERAPEUTIC APPLICATION
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Neurovascular Devices Market: Distribution by Therapeutic Application, 2019, current year and 2035
15.4. Neurovascular Devices Market for Ischemic Stroke, till 2035
15.5. Neurovascular Devices Market for Aneurysm, till 2035
15.6. Neurovascular Devices Market for Stenosis, till 2035
15.7. Neurovascular Devices Market for Arteriovenous Malformations (AVMs), till 2035
15.8. Data Triangulation and Validation
16. NEUROVASCULAR DEVICES MARKET, BY END-USERS
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Neurovascular Devices Market: Distribution by End-users, 2019, current year and 2035
16.4. Neurovascular Devices Market for Hospitals and Specialty Clinics, till 2035
16.5. Neurovascular Devices Market for Ambulatory Care Centers, till 2035
16.6. Neurovascular Devices Market for Other End-users, till 2035
16.7. Data Triangulation and Validation
17. NEUROVASCULAR DEVICES MARKET, BY KEY GEOGRAPHICAL REGIONS
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Neurovascular Devices Market: Distribution by Key Geographical Regions, 2019, current year and 2035
17.4. Neurovascular Devices Market in North America, till 2035
17.5. Neurovascular Devices Market in Europe, till 2035
17.6. Neurovascular Devices Market in Asia-Pacific, till 2035
17.7. Neurovascular Devices Market in Middle East and North Africa, till 2035
17.8. Neurovascular Devices Market in Latin America, till 2035
17.9. Data Triangulation and Validation
18. Neurovascular devices MARKET: KEY Leading players
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Neurovascular Devices Market: Distribution by Key Leading Players
18.4. Data Triangulation and Validation
19. CONCLUSION
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION

ページTOPに戻る

List of Tables/Graphs

Table 6.1 Neurovascular Devices Market: Information on Developer, Status of Development, Region of Approval, Type of Device, Shelf Life and Method of Sterilization
Table 6.2 Neurovascular Devices: Information on Therapeutic Application, Material of Fabrication, Coating Material of Device, Working Length, Full Length and Outer Diameter
Table 6.3 Neurovascular Devices: List of Developers
Table 7.1 List of Companies: Detailed Profiles
Table 7.2 Johnson & Johnson: Company Overview
Table 7.3 Johnson & Johnson: Neurovascular Device Portfolio
Table 7.4 Johnson & Johnson: Recent Developments and Future Outlook
Table 7.5 Medtronic: Company Overview
Table 7.6 Medtronic: Neurovascular Device Portfolio
Table 7.7 Medtronic: Recent Developments and Future Outlook
Table 7.8 MicroVention: Company Overview
Table 7.9 MicroVention: Neurovascular Device Portfolio
Table 7.10 Penumbra: Company Overview
Table 7.11 Penumbra: Neurovascular Device Portfolio
Table 7.12 Stryker: Company Overview
Table 7.13 Stryker: Neurovascular Devices Portfolio
Table 7.14 Stryker: Recent Developments and Future Outlook
Table 7.15 List of Companies: Short Profiles
Table 7.16 Acandis: Company Overview
Table 7.17 Acandis: Neurovascular Device Portfolio
Table 7.18 Achieva Medical: Company Overview
Table 7.19 Achieva Medical: Neurovascular Device Portfolio
Table 7.20 Balt: Company Overview
Table 7.21 Balt: Neurovascular Device Portfolio
Table 7.22 HeMo Bioengineering: Company Overview
Table 7.23 HeMo Bioengineering: Neurovascular Device Portfolio
Table 7.24 Phenox: Company Overview
Table 7.25 Phenox: Neurovascular Device Portfolio
Table 7.26 Shanghai HeartCare Medical Technology: Company Overview
Table 7.27 Shanghai Heartcare Medical Technology: Neurovascular Device Portfolio
Table 7.28 Zylox-Tonbridge: Company Overview
Table 7.29 Zylox-Tonbridge: Neurovascular Device Portfolio
Table 9.1 Neurovascular Devices Market: List of Partnerships and Collaborations, Since 2019
Table 9.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 10.1 Neurovascular Devices: List of Funding and Investments, Since 2019
Table 20.1 Neurovascular Devices: Distribution by Status of Development
Table 20.2 Neurovascular Devices: Distribution by Type of Device
Table 20.3 Neurovascular Devices: Distribution by Therapeutic Application
Table 20.4 Neurovascular Devices: Distribution by Type of Device and Therapeutic Application
Table 20.5 Neurovascular Devices: Distribution by Material of Fabrication
Table 20.6 Neurovascular Devices: Distribution by Coating Material of Device
Table 20.7 Neurovascular Device Developers: Distribution by Year of Establishment
Table 20.8 Neurovascular Device Developers: Distribution by Company Size
Table 20.9 Neurovascular Device Developers: Distribution by Location of Headquarters (Region)
Table 20.10 Neurovascular Device Developers: Distribution by Location of Headquarters (Country)
Table 20.11 Neurovascular Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Table 20.12 Most Active Developers: Distribution by Number of Neurovascular Devices Developed
Table 20.13 Johnson & Johnson: Annual Revenues, FY 2020 Onwards (USD Million)
Table 20.14 Medtronic: Annual Revenues, FY 2020 Onwards (USD Billion)
Table 20.15 MicroVention: Annual Revenues, FY 2020 Onwards (Yen Billion)
Table 20.16 Penumbra: Annual Revenues, FY 2019 Onwards (USD Million)
Table 20.17 Stryker: Annual Revenues, FY 2019 Onwards (USD Billion)
Table 20.18 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2019
Table 20.19 Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.20 Partnerships and Collaborations: Distribution by Year and Type of Partnership, Since 2019
Table 20.21 Partnerships and Collaborations: Distribution by Type of Partner
Table 20.22 Partnerships and Collaborations: Distribution by Year and Type of Partner, Since 2019
Table 20.23 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 20.24 Partnerships and Collaborations: Distribution by Type of Device
Table 20.25 Partnerships and Collaborations: Distribution by Therapeutic Application
Table 20.26 Most Active Players: Distribution by Number of Partnerships
Table 20.27 Partnerships and Collaborations: Local and International Agreements
Table 20.28 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 20.29 Funding and Investments: Cumulative Year-wise Trend, Since 2019
Table 20.30 Funding and Investments: Distribution by Type of Funding
Table 20.31 Funding and Investments: Distribution by Year and Type of Funding, Since 2019
Table 20.32 Funding and Investments: Distribution by Amount Invested, Since 2019 (USD Million)
Table 20.33 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Table 20.34 Funding and Investments: Distribution by Geography (Region)
Table 20.35 Most Active Players: Distribution by Number of Funding Instances
Table 20.36 Most Active Players: Distribution by Amount Raised (USD Million)
Table 20.37 Leading Investors: Distribution by Number of Funding Instances
Table 20.38 Funding and Investment Summary, Since 2019 (USD Million)
Table 20.39 Global Demand for Neurovascular Devices, till 2035 (Million Units)
Table 20.40 Global Demand for Neurovascular Devices: Distribution by Type of Device, till 2035 (Million Units)
Table 20.41 Global Demand for Neurovascular Devices: Distribution by Therapeutic Application, till 2035 (Million Units)
Table 20.42 Global Demand for Neurovascular Devices: Distribution by Key Geographical regions, till 2035 (Million Units)
Table 20.43 Global Neurovascular Devices Market, till 2035 (USD Million)
Table 20.44 Global Neurovascular Devices Market, till 2035: Conservative Scenario (USD Million)
Table 20.45 Global Neurovascular Devices Market, till 2035: Optimistic Scenario (USD Million)
Table 20.46 Neurovascular Devices Market: Distribution by Type of Device, 2019, current year and 2035
Table 20.47 Neurovascular Devices Market for Neurothrombectomy Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.48 Neurovascular Devices Market for Embolization Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.49 Neurovascular Devices Market for Angioplasty Devices, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.50 Neurovascular Devices Market: Distribution by Therapeutic Application, 2019, current year and 2035
Table 20.51 Neurovascular Devices Market for Ischemic Stroke, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.52 Neurovascular Devices Market for Aneurysm, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.53 Neurovascular Devices Market for Stenosis, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.54 Neurovascular Devices Market for Arteriovenous Malformations (AVMs), till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.55 Neurovascular Devices Market: Distribution by End-users, 2019, current year and 2035
Table 20.56 Neurovascular Devices Market for Hospitals and Specialty Clinics, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.57 Neurovascular Devices Market for Ambulatory Care Centers, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.58 Neurovascular Devices Market for Other End-users, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.59 Neurovascular Devices Market: Distribution by Key Geographical Regions, 2019, current year and 2035
Table 20.60 Neurovascular Devices Market in North America, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.61 Neurovascular Devices Market in Europe, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.62 Neurovascular Devices Market in Asia-Pacific, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.63 Neurovascular Devices Market in Middle East and North Africa, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.64 Neurovascular Devices Market in Latin America, till 2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 20.65 Neurovascular Devices Market: Distribution by Key Leading Players